Income and long-term breast cancer survival: comparisons of vulnerable urban places in Ontario and California by Gorey, Kevin M.
University of Windsor
Scholarship at UWindsor
Social Work Publications Department of Social Work
2010
Income and long-term breast cancer survival:
comparisons of vulnerable urban places in Ontario
and California
Kevin M. Gorey
University of Windsor
Follow this and additional works at: http://scholar.uwindsor.ca/socialworkpub
Part of the Epidemiology Commons, Health Services Research Commons, International Public
Health Commons, Social Work Commons, and the Women's Health Commons
This Article is brought to you for free and open access by the Department of Social Work at Scholarship at UWindsor. It has been accepted for inclusion
in Social Work Publications by an authorized administrator of Scholarship at UWindsor. For more information, please contact
scholarship@uwindsor.ca.
Recommended Citation
Gorey, Kevin M.. (2010). Income and long-term breast cancer survival: comparisons of vulnerable urban places in Ontario and
California. The Breast Journal, 16 (4), 416-419.
http://scholar.uwindsor.ca/socialworkpub/44
Income and Long-Term Breast Cancer Survival: Comparisons of
Vulnerable Urban Places in Ontario and California
Kevin M. Gorey, PhD, MSW*, Karen Y. Fung, PhD†, Isaac N. Luginaah, PhD‡, Eric J.
Holowaty, MD§, and Caroline Hamm, MD¶
* School of Social Work, University of Windsor, Windsor, Ontario, Canada
† Department of Mathematics and Statistics, University of Windsor, Windsor, Ontario, Canada
‡ Department of Geography, University of Western Ontario, London, Ontario, Canada
§ Population Studies and Surveillance, Cancer Care Ontario, Toronto, Ontario, Canada
¶ Clinical Trials and Research, Windsor Regional Cancer Center, Windsor, Ontario, Canada
Abstract
Effects of socioeconomic status on the long-term survival of 808 women with node-negative
breast cancer in Canada and the United States were observed. Ontario and California samples
diagnosed between 1988 and 1990 were followed until 2006. Socioeconomic data were taken from
population censuses. Compared with their California counterparts, residents of low-income urban
areas in Ontario experienced a significant 15-year survival advantage (RR = 1.66 [95% CI: 1.00,
2.76]). In these and other vulnerable, lower-middle- to working-class neighborhoods, significantly
more Ontario residents gained access to adjuvant radiation therapy (RR = 1.75 [1.21, 2.53]) which
seemed associated with better long-term survival (RR = 1.36 [0.99, 1.86]). This stage-adjusted,
historical cohort analysis suggests much greater cancer care equity in Canada than in the United
States.
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Studies of breast cancer survival in diverse Canadian and United States metropolitan areas
have tested a health insurance hypothesis and consistently found advantaged survival among
Canadians in vulnerable low-income neighborhoods (1–4). None of those studies accounted
for stage of disease at diagnosis. This one did. Recent staged analyses observed Canadian
advantages in low-income Ontario places versus similar California places on 5-year node-
positive breast cancer survival (5). Such Canadian women gained greater access to adjuvant
chemo- and radio-therapies (6). Long-term investigations in this field are rare (7), and no
previous international comparative study followed patients for more than 5 years. This
Ontario-California cohort did. Consistent with a health insurance theory, we hypothesized
that significantly more low-income Canadian women with node-negative breast cancer
would enjoy long-term survival.
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METHODS
A historical cohort of 1,802 women diagnosed between 1988 and 1990 with
nonmetastasized, invasive breast cancer in Ontario and California were randomly selected.
No significant difference on long-term survival was observed for node-positive disease or
for node-negative disease in rural places. So, this study explored its node-negative-specific
hypothesis in urban places. Ontario and California cancer registries, respectively, selected
366 and 442 node-negative cases from large (Toronto and San Francisco) and small cities
(Windsor and Modesto) (8–10). Census tract-based socioeconomic status measures (“low-
income” in Canada and US “poverty”) have defined income deciles (11,12). They
aggregated similar low-income areas in both countries. The lowest income deciles were
defined in US dollars as follows: Ontario—median low-income household prevalence
(34.6%, $20,260) and California—poor (28.7%, $19,190) (13). Socioeconomically
vulnerable areas (5th, 7th, and 10th lowest deciles) that demonstrated the poorest US
survival were aggregated and defined as follows: Ontario (16.0%, $33,250) and California
(10.0%, $30,060). They were similar to previously studied decile areas in Hawaii that were
more predominantly represented not only by the poor but also by the near poor (up to 200%
of the federal poverty criterion) (2,12). Disease stage and treatments were reliably abstracted
from patient charts (average κ coefficient 0.95) (14–16). Cohorts followed until 2006 were
able to detect 20% survival differences (α = 0.05 and 1−β = Power = 0.80) (17). All-cause
(15-year) survival was used because, although survival is highly accurate in these registries,
the underlying cause of death is not (8). Survival rate ratios (RR) were age-adjusted and
confidence intervals (95% CI) were based on the Mantel–Haenszel chi-squared test (18,19).
Methodological details have been reported (5).
RESULTS
Long-term node-negative breast cancer survival was not associated with income in Ontario,
but it was in California. As hypothesized for the lowest income places, significantly
advantaged Canadian survival was observed (RR = 1.66), and Canadian women in
vulnerable areas were similarly advantaged (RR = 1.35 [95% CI: 1.01, 1.81], not shown in
Table 1). These findings did not differ by place size. Analyses among vulnerable samples
found that women in such Ontario areas were more likely to have received a lumpectomy
than were their counterparts in California (RR = 1.86 [1.37, 2.52]), but the lumpectomy-
mastectomy difference was not itself associated with long-term survival. Potentially
vulnerable women in Ontario were also more likely to have received adjuvant radiation
therapy (age-adjusted rates of 0.427 versus 0.244, RR = 1.75 [1.21, 2.53]) which did seem
associated with better long-term survival (RR = 1.36 [0.99, 1.86]). There were no significant
between-country difference on tumor size, receipt of adjuvant chemotherapy or on wait-
times for initial surgical or adjuvant treatments.
DISCUSSION
This study found that residents of vulnerable low-income urban areas in Ontario with node-
negative breast cancer were significantly advantaged on 15-year survival as compared with
similar women in California. Such neighborhoods are more predominantly represented, not
only by the poor, but also by the near poor or cyclically poor in middle- to working-class
neighborhoods, who are more likely to be inadequately insured in the US (2,12,20). In an era
of breast cancer treatment innovations, this study observed that relatively poor women in
Ontario gained access to them (lumpectomy and adjuvant radiation therapy) more readily
than their counterparts in California, and such access, particularly to adjuvant radiotherapy
seemed to matter in terms of their long-term survival chances. These findings are consistent
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with well known socioeconomic (health insurance)-breast cancer care gradients in the US
and nonassociations in Canada (Ontario) (5,21–27).
One might wonder if it could be race/ethnicity, rather than SES that accounts for the
observed survival differences. We could not statistically adjust for this factor as the OCR
does not code race/ethnicity. We were able, however, to replicate key findings with the
following conservative comparison: non-Hispanic white women in California versus the
entire diverse sample of women in Ontario. After excluding all racial or ethnic minority
group members from the California sample (18 African-American, 33 Hispanic, 19 Asian
American and 2 women of other racial/ethnic backgrounds) key socioeconomic gradients
were maintain. For example, the 15-year survival gradient seemed as steep or possibly even
steeper within California (lowest versus highest income areas RR = 0.48 95% CI: 0.27,
0.84). Furthermore, the Canadian survival advantage seemed also to have been maintained
in the lowest income areas (Ontario versus. California lowest income areas RR = 1.84 [90%
CI: 1.10, 3.09]). Therefore, we think that race, per se, or race the biologic, rather than the
social construction, is probably not a potent alternative explanation for this study’s pattern
of findings. This study might also be limited by its focus on all-cause, rather than cancer-
specific or disease-free survival. For the following reasons we think not. The underlying
cause of “noncancer” deaths can often be directly associated with nontreatment or even with
cancer treatment complications (28). And although length of survival is highly accurate in
these cancer registries, the underlying cause of death is not (8). Probably of most
importance, exploratory analyses, limited to women under the age of 50 (nearly all deaths
due to cancer), replicated key findings. Although this study was able to account for a
number of important factors (age, income, place, and disease stage at diagnosis), it could not
account for notable others such as comorbid conditions and body mass index. Previous
studies, however, have suggested that their socioeconomic distributions are probably quite
similar in the two, culturally similar, developed nations under study, Canada and the United
States (2,4,29–31). Therefore, we think that such factors probably did not potently confound
this study’s findings.
CONCLUSION
More inclusive health insurance coverage in Canada versus the United States seems the most
plausible explanation for the observed Canadian advantages on treatment access and
survival.
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